therapeutics


Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

therapeutics

the branch of medicine concerned with the treatment of disease
References in periodicals archive ?
Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
VP for Clinical Research at ExonHit Therapeutics, who played a major role in the clinical development of Rilutek.
2 List of Figures 10 2 Oncology Therapeutics Market in India - Introduction 11 3 Oncology Therapeutics Market in India - Market Overview 12 3.
is a biopharmaceutical company developing monoclonal antibody-based therapeutics to fight cancer and other life-threatening and debilitating diseases.
Any statements in this press release about future expectations, plans and prospects for Critical Therapeutics, Inc.
Analysis of the current and future competition in the seven key countries Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics market.
Altea Therapeutics has demonstrated in several clinical studies that its patented PassPort[TM] transdermal system achieves what existing patches are unable to do, namely the continuous delivery through the skin of compounds that are typically administered by needle injections.
Data and analysis on the substance abuse therapeutics market in the leading geographies of the world - the US, the UK, Germany, France, Italy, Spain, and Japan.
The European autoimmune diseases therapeutics market is set to witness sustained growth in the coming years.
List of Figures Figure 1: Classification of Methicillin-Resistant Staphylococcus aureus Infection 9 Figure 2: Methicillin-Resistant Staphylococcus aureus Therapeutics - Comparison of HA-MRSA and CA-MRSA Infections 10 Figure 3: Methicillin-Resistant Staphylococcus aureus Therapeutics - Treatment Flow Analysis 12 Figure 4: KOL Insights, Methicillin - Resistant Staphylococcus aureus in the US 12 Figure 5: Methicillin-Resistant Staphylococcus aureus Therapeutics - Skin Infection (abscess) 14 Figure 6: Methicillin-Resistant Staphylococcus aureus Therapeutics - Comparison of Method of Detection 16 Figure 7: Virulence factors of S.
Critical Therapeutics licensed patent rights related to the modulation of this pathway by pharmacologic agents and vagal nerve stimulation from the Feinstein Institute in 2003.